相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular mechanisms underlying cellular effects of human MEK1 mutations
Robert A. Marmion et al.
MOLECULAR BIOLOGY OF THE CELL (2021)
ERK signalling: a master regulator of cell behaviour, life and fate
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
The duality of human oncoproteins: drivers of cancer and congenital disorders
Pau Castel et al.
NATURE REVIEWS CANCER (2020)
The Nuclear Translocation of Mitogen-Activated Protein Kinases: Molecular Mechanisms and Use as Novel Therapeutic Target
Karen Flores et al.
NEUROENDOCRINOLOGY (2019)
The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway
Mylene Tajan et al.
ENDOCRINE REVIEWS (2018)
Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties
Yijun Gao et al.
CANCER DISCOVERY (2018)
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer
Abbie E. Fearon et al.
CELL REPORTS (2018)
PHLDA1, another PHLDA family protein that inhibits Akt
Yu Chen et al.
CANCER SCIENCE (2018)
Intrinsically active MEK variants are differentially regulated by proteinases and phosphatases
Merav Ordan et al.
SCIENTIFIC REPORTS (2018)
BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity
Caroline M. Emery et al.
MOLECULAR CANCER RESEARCH (2017)
Tracing Information Flow from Erk to Target Gene Induction Reveals Mechanisms of Dynamic and Combinatorial Control
Maxwell Z. Wilson et al.
MOLECULAR CELL (2017)
PI(3,4,5)P3 Engagement Restricts Akt Activity to Cellular Membranes
Michael Ebner et al.
MOLECULAR CELL (2017)
Divergent effects of intrinsically active MEK variants on developmental Ras signaling
Yogesh Goyal et al.
NATURE GENETICS (2017)
Insights into the binding mode of MEK type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinome
Zheng Zhao et al.
PLOS ONE (2017)
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF
Jaclyn F. Hechtman et al.
MOLECULAR CANCER RESEARCH (2016)
The ERK cascade inhibitors: Towards overcoming resistance
Galia Maik-Rachline et al.
DRUG RESISTANCE UPDATES (2016)
Opposing effects of Elk-1 multisite phosphorylation shape its response to ERK activation
Anastasia Mylona et al.
SCIENCE (2016)
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Matthew M. Gubin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling
Xiaoqi Wang et al.
Oncotarget (2015)
Perinatal Features of the RASopathies: Noonan Syndrome, Cardiofaciocutaneous Syndrome and Costello Syndrome
Angela Myers et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
Cardio-Facio-Cutaneous Syndrome: Clinical Features, Diagnosis, and Management Guidelines
Mary Ella M. Pierpont et al.
PEDIATRICS (2014)
MYC Phosphorylation at Novel Regulatory Regions Suppresses Transforming Activity
Amanda R. Wasylishen et al.
CANCER RESEARCH (2013)
αC helix displacement as a general approach for allosteric modulation of protein kinases
Lorenzo Palmieri et al.
DRUG DISCOVERY TODAY (2013)
Secretome-Based Identification of TFPI2, A Novel Serum Biomarker for Detection of Ovarian Clear Cell Adenocarcinoma
Noriaki Arakawa et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Engineering human MEK-1 for structural studies: A case study of combinatorial domain hunting
Christoph Meier et al.
JOURNAL OF STRUCTURAL BIOLOGY (2012)
TDAG51 mediates epithelial-to-mesenchymal transition in human proximal tubular epithelium
Rachel E. Carlisle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Nikhil Wagle et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK
Damian F. Brennan et al.
NATURE (2011)
Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors
Thierry O. Fischmann et al.
BIOCHEMISTRY (2009)
MEK1 mutations confer resistance to MEK and B-RAF inhibition
Caroline M. Emery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway:: genotype-phenotype relationships and overlap with Costello syndrome
Caroline Nava et al.
JOURNAL OF MEDICAL GENETICS (2007)
A novel HSF1-mediated death pathway that is suppressed by heat shock proteins
Naoki Hayashida et al.
EMBO JOURNAL (2006)
TRANSFAC (R) and its module TRANSCompel (R): transcriptional gene regulation in eukaryotes
V. Matys et al.
NUCLEIC ACIDS RESEARCH (2006)
Regulation of raf-1 by direct feedback phosphorylation
MK Dougherty et al.
MOLECULAR CELL (2005)
Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1)
D Tasdemir et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
分享论文
